Cited by

• β-Elemene suppresses tumor growth of diffuse large B-cell lymphoma through regulating lncRNA HULC-mediated apoptotic pathway.

  Hu T, Gao Y. Hu T, et al. Biosci Rep. 2020 Feb 28;40(2):BSR20190804. doi: 10.1042/BSR20190804. Biosci Rep. 2020. PMID: 32010942 Free PMC article.
• Targeting AURKA to induce synthetic lethality in CREBBP-deficient B-cell malignancies via attenuation of MYC expression.

  Sun Y, Chen J, Hong JH, Xiao R, Teng Y, Wang P, Deng P, Yu Z, Chan JY, Chai KXY, Gao J, Wang Y, Pan L, Liu L, Liu S, Teh BT, Yu Q, Lim ST, Li W, Xu B, Ong CK, Tan J. Sun Y, et al. Oncogene. 2024 Jul;43(28):2172-2183. doi: 10.1038/s41388-024-03065-6. Epub 2024 May 23. Oncogene. 2024. PMID: 38783101
• Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas.

  Tosolini M, Algans C, Pont F, Ycart B, Fournié JJ. Tosolini M, et al. Oncoimmunology. 2016 May 19;5(7):e1188246. doi: 10.1080/2162402X.2016.1188246. eCollection 2016 Jul. Oncoimmunology. 2016. PMID: 27622044 Free PMC article.
• AID assists DNMT1 to attenuate BCL6 expression through DNA methylation in diffuse large B-cell lymphoma cell lines.

  Jiao J, Lv Z, Zhang P, Wang Y, Yuan M, Yu X, Otieno Odhiambo W, Zheng M, Zhang H, Ma Y, Ji Y. Jiao J, et al. Neoplasia. 2020 Mar;22(3):142-153. doi: 10.1016/j.neo.2020.01.002. Epub 2020 Feb 12. Neoplasia. 2020. PMID: 32062068 Free PMC article.
• Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing.

  Quentmeier H, Drexler HG, Hauer V, MacLeod RA, Pommerenke C, Uphoff CC, Zaborski M, Berglund M, Enblad G, Amini RM. Quentmeier H, et al. PLoS One. 2016 Dec 1;11(12):e0167599. doi: 10.1371/journal.pone.0167599. eCollection 2016. PLoS One. 2016. PMID: 27907212 Free PMC article.